Estriol
Estriol Price range: $ 64,00 through $ 137,00
Back to products
Ethionamide
Ethionamide Price range: $ 49,00 through $ 172,00

Estriol Cream

Price range: $ 13,00 through $ 93,00

Estriol Cream is an effective topical estrogen therapy designed to alleviate symptoms associated with menopause. It works by replenishing local estrogen levels to restore the natural health and moisture of vaginal tissues. This treatment provides targeted relief from common discomforts such as vaginal dryness, itching, and irritation. Regular application helps improve tissue elasticity and reduces pain during intimate activities caused by vulvovaginal atrophy. The smooth formula ensures convenient application and promotes lasting comfort for women experiencing hormonal changes.

Active substance: Estriol
SKU: Estriol Cream Categories: ,
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM

Each dosage option has its own packaging choices.

Description

Estriol Cream belongs to a class of topical gynecological and dermatological preparations containing short-acting estrogens derived from natural or synthetic steroid precursors. In the United States, estriol cream is dispensed in accordance with applicable federal and state regulations for localized application to urogenital tissues. Proper clinical evaluation ensures that topical estrogen therapy aligns with individual physiological needs and safety profiles.

This reference overview outlines the primary pharmacologic characteristics, administration protocols, potential drug interactions, and precautionary measures required for safe administration.

Active ingredient (INN) Estriol
Therapeutic class Estrogen (Topical / Gynecological)
Dosage form Topical / Vaginal Cream
Route of administration Intravaginal / Cutaneous
Primary purpose Management of local urogenital estrogen deficiency symptoms
Storage Store at 20°C to 25°C (68°F to 77°F)

How the drug works

The active constituent, estriol, is a weak endogenous estrogen with a selective affinity for nuclear estrogen receptors, particularly estrogen receptor beta (ER-β) situated in the lower urogenital tract. Unlike estradiol, estriol exhibits a relatively short nuclear retention time in target tissues, typically binding for approximately 1 to 4 hours. This brief nuclear occupancy stimulates local epithelial cellular proliferation, restores normal vaginal glycogen content, and encourages the re-establishment of protective Lactobacillus flora. Consequently, the local vaginal pH drops toward physiological acidic levels (pH 3.8 to 4.5), reinforcing the mucosal barrier without inducing substantial systemic endometrial proliferation when applied as directed.

Main uses

Estriol cream is primarily utilized for the management of localized urogenital symptoms associated with estrogen deficiency, particularly during postmenopause or surgical menopause. Clinical indications include vulvovaginal atrophy, characterized by vaginal dryness, burning, dyspareunia (painful intercourse), and vulvar itching. Additionally, localized estrogen administration is employed as supportive therapy in the treatment of recurrent lower urinary tract infections or mild urinary urgency linked to tissue thinning in the trigone and urethra. Off-label applications for facial dermatological thinning or localized scar management must be evaluated strictly under medical oversight due to limited FDA-approved labeling for non-gynecological sites.

Dosing schedule

Dosage regimens are individualized based on symptom severity and physiological response. Typically, initial therapy involves intravaginal application of 0.5 mg of estriol (using a calibrated applicator) administered once daily at bedtime for an initial induction period of 2 to 3 weeks. Following symptomatic improvement, the dose is stepped down to a maintenance schedule of 0.5 mg applied twice weekly. The cream should be inserted into the vagina prior to sleep to maximize mucosal retention and local absorption. Dosage adjustments must be determined by a prescribing healthcare provider based on periodic clinical reassessments, aiming for the lowest effective dose for the shortest duration.

What happens in the body

Following local intravaginal administration, estriol is absorbed through the vaginal mucosa into the local vascular network. However, because estriol is rapidly cleared and metabolized, peak serum concentrations remain significantly lower compared to oral administration or systemic estradiol formulations. Estriol binds weakly to sex hormone-binding globulin (SHBG) and extensively to serum albumin. Hepatic metabolism occurs predominantly via conjugation into estriol glucuronides and sulfates, which are subsequently excreted by the kidneys into urine. Due to its rapid clearance rate, systemic accumulation is minimal under standard maintenance regimens, reducing systemic estrogenic effects relative to potent systemic estrogens.

Compatibility with other medicines

Although systemic absorption of intravaginal estriol is limited, co-administration with strong hepatic enzyme inducers or inhibitors may alter local or circulating steroid levels. Cytochrome P450 3A4 (CYP3A4) inducers, such as carbamazepine, phenobarbital, rifampin, and St. John’s wort, can potentially accelerate the clearance of estriol, diminishing its therapeutic efficacy. Conversely, potent CYP3A4 inhibitors like ketoconazole, clarithromycin, or ritonavir may modestly elevate local or systemic tissue exposure. Concomitant use of other topical vaginal products, including spermicides, antifungals, or lubricants, should be spaced appropriately to prevent altered cream stability or impaired mucosal contact.

Adverse reactions

Topical estriol cream is generally well-tolerated, though localized adverse reactions can occur during early treatment phases. Frequent localized effects include transient vaginal irritation, mild burning sensations, erythema, and increased vaginal discharge. As tissue integrity improves, these localized symptoms typically subside. Systemic side effects are rare but may include mild breast tenderness, peripheral fluid retention, spotty uterine bleeding or spotting, and transient headaches. Patients experiencing persistent pelvic pain, unexpected vaginal bleeding, or severe allergic cutaneous reactions should discontinue application and consult their managing clinician immediately for diagnostic evaluation.

Important precautions

Estriol cream is contraindicated in patients with a history of known or suspected estrogen-dependent neoplasia, such as breast carcinoma or endometrial cancer, active or historical deep vein thrombosis, pulmonary embolism, or unexplained genital bleeding. Cautious monitoring is warranted in individuals with hypertension, endometriosis, hepatic impairment, or severe hypertriglyceridemia. Periodic clinical evaluation of endometrial status and breast health is recommended for long-term users. Healthcare providers must evaluate individual cardiovascular and oncological risk factors prior to initiating therapy, adhering strictly to federal and state prescriber guidelines.

Practical tips

Proper administration requires maintaining strict hygiene. Wash hands thoroughly with soap and water prior to and after handling the applicator and cream. Wash the reusable applicator with warm water and mild soap after each application, allowing it to air dry completely before re-assembly. Avoid using harsh chemical cleaners or boiling water on plastic applicators. To prevent staining of garments, patients may utilize thin panty liners during initial days of treatment.

Special populations

Estriol cream is contraindicated during pregnancy due to lack of therapeutic necessity and potential risk to fetal development. Estrogens can pass into breast milk and decrease lactation quality and volume; therefore, use during breastfeeding requires explicit risk-benefit evaluation by a physician. In pediatric populations, safety and efficacy have not been established, and the product is not indicated. Elderly patients over 65 years of age require routine monitoring for cardiovascular and oncological safety parameters.

If you skip a dose

If a scheduled dose is missed, apply the cream as soon as remembered on that day, provided it is not near the time for the next scheduled dose. If the next application time is approaching, skip the missed application and resume the standard regimen. Never double the dose or apply extra cream to compensate for a missed dose, as this increases the likelihood of localized irritation.

Storage and expiration

Store estriol cream at controlled room temperature between 20°C and 25°C (68°F to 77°F), avoiding exposure to excessive heat, direct sunlight, or freezing temperatures. Keep the tube tightly capped when not in use to prevent desiccation. Ensure the container is stored out of reach of children and domestic pets. Safely discard any unused cream past the expiration date printed on the tube packaging.

Frequently asked questions

Does estriol cream cause systemic side effects like weight gain or high blood pressure?

Because estriol is a short-acting estrogen applied locally in microgram doses, systemic absorption remains low under standard maintenance protocols. Consequently, systemic effects such as significant weight gain or blood pressure spikes are extremely rare compared to oral hormone replacement therapies.

How long does it take for estriol cream to relieve vaginal dryness?

Initial symptomatic improvement in mucosal hydration and tissue comfort is typically observed within 1 to 2 weeks of consistent daily application. Complete restoration of epithelial thickness and physiological pH generally requires 3 to 6 weeks of continuous treatment as prescribed.

Can estriol cream be used concurrently with barrier contraceptives?

Some cream bases contain oily excipients or mineral oils that may weaken latex condoms, diaphragms, or cervical caps, reducing their contraceptive efficacy and tear resistance. Check the specific vehicle composition or consult a pharmacist before relying on latex barrier devices concurrently.

What should be done if unexpected vaginal spotting occurs during treatment?

Unexplained vaginal bleeding or spotting requires prompt clinical assessment by a healthcare provider to rule out endometrial changes or other underlying pathologies. Treatment should be temporarily suspended until a formal medical evaluation is completed.

Is routine endometrial monitoring required while using local estriol cream?

For low-dose, short-term local applications, routine endometrial biopsy is generally not required unless symptoms like unexpected bleeding occur. However, prolonged use beyond 6 to 12 months requires periodic clinical follow-up to ensure safety.

In accordance with FDA regulatory oversight and state pharmacy regulations.

This text is for informational purposes only and does not constitute individual medical advice.

Additional information
Dosage

15 gm

Package

1 tubes

,

3 tubes

,

6 tubes

,

9 tubes

Ενεργός Ουσία